Biostrap Announces The Launch Of Kairos, Setting A New Digital Health Standard For Stress Resilience Measurement And Heart Rate Variability Insights
AUSTIN, Texas, July 19, 2023 /PRNewswire/ -- Biostrap USA LLC, ("Biostrap") an industry leader in providing scalable and customizable biosensor-based precision health monitoring solutions, announced today the launch of their new wearable device, Biostrap Kairos. Accompanied by the new Vital Science app, Biostrap introduces a revolutionary data visualization of the autonomic nervous system, offering an unprecedented quantification of the sympathetic and parasympathetic branches from a wrist-worn device. Such measurements previously were only available to researchers while using uncomfortable electrocardiogram chest straps.
- "We are thrilled to launch Kairos and our new Spot Check feature," Sameer Sontakey, Biostrap CEO and co-founder said.
- It is a wrist-worn device but has a modular design allowing it to also be positioned on the forearm or bicep.
- Kairos underwent extensive testing by key thought leaders in heart rate variability research before its official launch.
- This is yet another demonstration that PPG can be used to estimate HRV and that pulse rate variability (i.e.